| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.001 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.095 | 0.001 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |